September 8, 2025 - Health Technology Insights

September 8, 2025
HealthTech Media Room
Healthcare Staffing, HealthTech News, news, News

Termeer Institute Appoints Catharine Smith as Chief Executive Officer

The Termeer Institute announced that Catharine Smith has been named Chief Executive Officer, reflecting her established leadership of the organization and the importance of the role to guide the...

September 8, 2025
HealthTech Media Room
HealthTech News, Medical Imaging, Medical Imaging Software, news, News

GE HealthCare to Distribute Flyrcado via CDL Nuclear Tech

GE HealthCare’s agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the reach of Flyrcado. GE HealthCare announced a Distribution and Services Agreement (DSA)...

September 8, 2025
HealthTech Media Room
Cancer, HealthTech News, news, News

SOPHiA GENETICS, Jessa Ziekenhuis Partner on Cancer Care

SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner...

September 8, 2025
HealthTech Media Room
Biotechnology, HealthTech News, News, news, Treatments

Dr Batra’s Launches XOGEN Hair Regrowth Treatment in UAE

Dr Batra’s®, the world’s largest chain of homeopathy clinics, present in the UAE for the last 14 years, has introduced XOGEN Advance – the most advanced, non-invasive hair regrowth treatment designed to...

September 8, 2025
HealthTech Media Room
Biotechnology, Cancer, Clinical Trials, Genomics and Precision Medicine, HealthTech News, News, news

Glenmark Starts Phase 3 Trial of Envafolimab for Stage III Non-Small Cell Lung Cancer

Clinical Trial Applications underway in Russia, Brazil, and Mexico Glenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, announced the initiation of a multi-country (ex-China) Phase 3 Clinical Trial for Envafolimab, a novel...

September 8, 2025
HealthTech Media Room
AI in Healthcare, AI/ML, Analytics & AI, Healthcare Staffing, HealthTech News, news, News

Health In Tech Expands Leadership to Boost AI and Revenue

Health In Tech, an Insurtech platform company backed by third-party AI technology, announced strategic leadership appointments designed to advance AI utilization and accelerate company growth. Dustin Plantholt, formerly our...

September 8, 2025
HealthTech Media Room
HealthTech News, news, News

Shilka S. Babu Offers Hybrid Concierge Care Program

Concierge Choice Physicians (CCP), the nation’s leading full-service concierge medical service provider, announces today that Medical Clinic of Houston (MCH) internal medicine physician Shilka S. Babu, M.D., is the latest physician...

September 8, 2025
HealthTech Media Room
AI in Healthcare, AI/ML, Analytics & AI, HealthTech News, news, News

Idorsia Launches IMPACT-HTN US Initiative for Hypertension Care

Multi-phase program to standardize treatment, generate real-world evidence, and explore AI-powered tools to improve outcomes for hypertension patients Idorsia Ltd announces a first-of-its-kind initiative with the Stanford Hypertension Center...

September 8, 2025
HealthTech Staff Writer
AI in Healthcare, Analytics & AI, Electronic Health Record (EHR) Software, HealthTech News, News, news, Patient Experience

275+ Duchenne Patients Enrolled in myTomorrows Programs

myTomorrows, a global health technology company that connects patients with approved treatment options, has announced it has referred 611 patients with Duchenne muscular dystrophy (DMD) around the world to...

September 8, 2025
HealthTech Staff Writer
Biotechnology, Cancer, Genomics and Precision Medicine, HealthTech News, News, news

Rybrevant Plus Lazcluze Prevents Resistance in EGFR Lung Cancer

Johnson & Johnson has released new findings from the Phase 3 MARIPOSA trial showing that combining RYBREVANT with LAZCLUZE as a first-line treatment significantly lowers the risk of resistance...

September 8, 2025
HealthTech Staff Writer
Biotechnology, Business, HealthTech News, News, news

Epigenic Therapeutics Raises $60 Million to Boost Epigenetic Drugs

Epigenic Therapeutics, a clinical-stage biotech company specializing in epigenetic-based drug development, has secured $60 million in a Series B funding round. The round was led by Lapam Capital and...

September 8, 2025
HealthTech Staff Writer
Biotechnology, Business, Genomics and Precision Medicine, HealthTech News, News, news

Servier Acquires Potential Treatment for Fragile X Syndrome

Servier, an independent international pharmaceutical group run by a foundation, has announced a final agreement to buy KER-0193 from Kaerus Bioscience. KER-0193 is a promising treatment for Fragile X...